Introducing the VITRA 689, the only commercially available PDT laser specifically designed to meet the evolving demands of ophthalmologists for photodynamic therapy (PDT). Developed by Quantel Medical, this innovative laser addresses the renewal needs of PDT technology and expands its clinical applications to include chronic central serous retinopathy and polypoidal choroidal vasculopathy (PCV). With a wavelength of 689 nm, the VITRA 689 stands out as the sole approved platform on the market utilizing advanced PDT technology, making it an essential tool for effective laser treatment in the management of various retinal conditions.